In toxicology research, bradykinin receptor antagonists are valuable tools for understanding the role of bradykinin in various pathological conditions. They are used in experimental models to dissect the pathways involved in inflammation and pain, providing insights that can lead to the development of new therapeutic strategies. Additionally, these studies help elucidate the potential toxic effects and safety profiles of new antagonists.
